Can the Combination of Incretin Agents and Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors Reconcile the Yin and Yang of Glucagon?

被引：10
|
作者：
Goldenberg, Ronald M. [1 ]
Verma, Subodh [2 ]
Perkins, Bruce A. [3 ]
Gilbert, Jeremy D. [4 ]
Zinman, Bernard [5 ]
机构：
[1] LMC Diabet & Endocrinol, Thornhill, ON, Canada
[2] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Dept Surg,Div Cardiac Surg, Toronto, ON, Canada
[3] Univ Toronto, Mt Sinai Hosp, Dept Med, Div Endocrinol & Metab, Toronto, ON, Canada
[4] Sunnybrook Hlth Sci Ctr, Div Endocrinol & Metab, Toronto, ON, Canada
[5] Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada
来源：
CANADIAN JOURNAL OF DIABETES | 2017年 / 41卷 / 01期
关键词：
TYPE-2; DIABETES-MELLITUS; PANCREATIC ALPHA-CELLS; DAPAGLIFLOZIN ADD-ON; DOUBLE-BLIND; POSTPRANDIAL GLUCAGON; BETA-CELLS; METFORMIN; THERAPY; SAXAGLIPTIN; SECRETION;
D O I：
10.1016/j.jcjd.2016.08.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6 / 9
页数：4
相关论文
共 50 条
  • [1] Role of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors
    Lusk, Kathleen A.
    Barnes, Nicole E.
    US PHARMACIST, 2016, 41 (11) : 38 - 42
  • [2] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Stroke
    Kimura, Genjiro
    CIRCULATION JOURNAL, 2017, 81 (06) : 898 - 898
  • [3] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Stroke - Reply
    Kaku, Kohei
    Lee, Jisoo
    Kaspers, Stefan
    Woerle, Hans J.
    George, Jyothis T.
    CIRCULATION JOURNAL, 2017, 81 (06) : 899 - 899
  • [4] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Benefits Versus Risk
    Jasleen, Bains
    Vishal, Gupta K.
    Sameera, Malepati
    Fahad, Molla
    Brendan, O'Brien
    Deion, Santander
    Pemminati, Sudhakar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [5] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Harms or Unexpected Benefits?
    Andreea, Munteanu Madalina
    Surabhi, Swarnkar
    Razvan-Ionut, Popescu
    Lucia, Ciobotaru
    Camelia, Nicolae
    Emil, Tufanoiu
    Tiberiu, Nanea Ioan
    MEDICINA-LITHUANIA, 2023, 59 (04):
  • [6] Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician's Guide
    Simes, Bryce C.
    MacGregor, Gordon G.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2019, 12 : 2125 - 2136
  • [7] Sodium-Glucose Cotransporter (SGLT2) inhibitors: A new Era in renovascular protection
    Berbari, Adel E.
    INTERNATIONAL JOURNAL CARDIOLOGY HYPERTENSION, 2020, 7
  • [8] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review
    Kalra S.
    Cardiology and Therapy, 2016, 5 (2) : 161 - 168
  • [9] Erratum to: Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review
    Sanjay Kalra
    Rakesh Sahay
    Manash P. Baruah
    Cardiology and Therapy, 2016, 5 (2) : 169 - 169
  • [10] Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors and Cardiovascular Outcomes: A Review of Literature
    Mani, Sweatha
    Balasubramanian, Abirami
    Veluswami, Keerthana
    Rao, Sudipta
    Aggarwal, Shailesh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
12345